Effects of oral continuous and transdermal cyclic 17-β estradiol and norethindrone acetate replacement therapy on platelet aggregation in postmenopausal women

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 47, Issue 8, 2002, Pages 651-655

  Kaplan, Petek Balkanli ^a   Gücer, Fatih ^a   Sayin, N Cenk ^a   Yüce, M Ali ^a   Yardim, Turgut ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

Platelet aggregation; Postmenopausal hormone replacement therapy; Postmenopause

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; ESTRADIOL; ESTRADIOL PLUS NORETHISTERONE ACETATE; LIPID; NORETHISTERONE; DRUG DERIVATIVE; NORETHISTERONE ACETATE;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HORMONE SUBSTITUTION; HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; AGE; BLOOD; DELAYED RELEASE FORMULATION; DRUG COMBINATION; ESTROGEN THERAPY; INTRADERMAL DRUG ADMINISTRATION; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PROSPECTIVE STUDY; TIME;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADULT; AGE FACTORS; DELAYED-ACTION PREPARATIONS; DRUG THERAPY, COMBINATION; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMAN; LIPIDS; MIDDLE AGE; NORETHINDRONE; PLATELET AGGREGATION; PLATELET COUNT; PROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; TIME FACTORS; HUMANS; MIDDLE AGED;

EID: 0036678649     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Passage of the menopause is followed by hemostatic changes
2. Hormonal replacement therapy in postmenopausal women and cardiovascular disease: An overview
3. Hormone replacement therapy reduces the reactivity of monocytes and platelets in whole blood: A beneficial effect on atherogenesis and thrombus formation?
4. The effect of estrogen replacement therapy on platelet aggregation and adenosine triphosphate release in postmenopausal women
5. Hormone replacement therapy and the cardiovascular system
6. Association of hormone replacement therapy with various cardiovascular risk factors in postmenopausal women
7. International consensus conference on postmenopausal hormone therapy and the cardiovascular system
8. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
9. Estrogens and the heart
10. Ovarian sex steroids and atherosclerosis
11. Hormone replacement therapy and hemostasis: Principles of a complex interaction
12. Risk of venous thromboembolism in users of hormone replacement therapy
13. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal estrogens
14. Prospective study of exogenous hormones and risk of pulmonary embolism in women
15. Hormone replacement therapy and risk of thromboembolism: Population based case-control study
16. Hormone replacement therapy and the risk of hospitalization for venous thromboembolism: A population-based study in southern Europe
17. Postmenopausal hormone therapy increases risk for venous thromboembolic disease
18. The pathogenesis of atherosclerosis
19. Effects of hormone replacement therapy on cardiovascular risk factors in postmenopausal women
20. Effects of oral combined hormone replacement therapy on platelet aggregation in postmenopausal women
21. The effect of natural estrogens on coagulation
22. Oral contraceptive steroid induced platelet coagulation hyperactivity: Dissociation of in vivo and in vitro effect
23. Paradoxical influence of estrogenic hormones on platelet endothelial cell interactions
24. Effect of 17beta-estradiol on inhibition of platelet aggregation in vitro is mediated by an increase in NO synthesis
25. Effects of hormone replacement therapy on hemostatic factors, lipid factors, and endothelial function in women undergoing surgical menopause: Implications for prevention of atherosclerosis
26. Increased mean platelet volume after estrogen replacement therapy
27. Estrogen replacement therapy decreases platelet-activating factor-acetylhydrolase activity in postmenopausal women